دانلود مقاله ISI انگلیسی شماره 115609
ترجمه فارسی عنوان مقاله

پیش بینی کننده های عصب روان شناختی پاسخ به درمان رفتاری شناختی برای اختلال استرس پس از سانحه در افراد مبتلا به بیماری روانی شدید

عنوان انگلیسی
Neuropsychological predictors of response to cognitive behavioral therapy for posttraumatic stress disorder in persons with severe mental illness
کد مقاله سال انتشار تعداد صفحات مقاله انگلیسی
115609 2018 7 صفحه PDF
منبع

Publisher : Elsevier - Science Direct (الزویر - ساینس دایرکت)

Journal : Psychiatry Research, Volume 259, January 2018, Pages 110-116

پیش نمایش مقاله
پیش نمایش مقاله  پیش بینی کننده های عصب روان شناختی پاسخ به درمان رفتاری شناختی برای اختلال استرس پس از سانحه در افراد مبتلا به بیماری روانی شدید

چکیده انگلیسی

This study examined whether cognitive functioning was related to treatment outcomes in persons with severe mental illness who received a cognitive behavioral therapy (CBT) program for co-occurring posttraumatic stress disorder (PTSD). The study sample was drawn from a larger controlled trial of 108 persons with severe mental illness and PTSD comparing the effects of CBT with treatment as usual on PTSD and related outcomes, with assessments conducted at baseline, post-treatment, and 3- and 6-month follow-ups. Among the 54 persons in CBT, 49 were administered a neuropsychological battery at baseline and 40 were exposed to the CBT program. Statistical analyses of these 40 participants were conducted to evaluate whether cognitive functioning was related to participation in the CBT program, completion of homework assignments, and improvements in PTSD, and other outcomes. Cognitive functioning was not related to participation in CBT or completion of homework. Lower cognitive functioning predicted less learning of information about PTSD at post-treatment and follow-up, but not less clinical benefit from CBT in PTSD diagnosis or symptoms, other symptoms, or health. The results suggest that cognitive impairment does not attenuate response to the CBT for PTSD program in persons with severe mental illness. Clinical Trials.gov Identifier: NCT00053690